1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.67%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
-177.61%
Negative gross profit growth while MAXN is at 73.39%. Joel Greenblatt would examine cost competitiveness or demand decline.
-80.71%
Negative EBIT growth while MAXN is at 71.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
33.93%
Operating income growth at 50-75% of MAXN's 66.50%. Martin Whitman would doubt the firm’s ability to compete efficiently.
-76.09%
Negative net income growth while MAXN stands at 73.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-75.00%
Negative EPS growth while MAXN is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-75.00%
Negative diluted EPS growth while MAXN is at 73.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.08%
Share change of 0.08% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.08%
Diluted share change of 0.08% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
83.73%
OCF growth at 75-90% of MAXN's 93.92%. Bill Ackman would demand better working capital management or cost discipline.
56.28%
FCF growth 50-75% of MAXN's 91.23%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-35.00%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-38.39%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
17.44%
3Y revenue/share CAGR above 1.5x MAXN's 7.06%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-132.84%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-168.88%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
91.47%
Positive 3Y OCF/share CAGR while MAXN is negative. John Neff might see a big short-term edge in operational efficiency.
-405.40%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-709.40%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-19.28%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-111.66%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-116.09%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-113.86%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.76%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-19.52%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-24.74%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-393.59%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-54.80%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.80%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-29.30%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.